As of May 22
| -4.86 / -3.16%|
The 28 analysts offering 12-month price forecasts for Bayer have a median target of 156.78, with a high estimate of 176.53 and a low estimate of 125.18. The median estimate represents a +5.29% increase from the last price of 148.90.
The current consensus among 30 polled investment analysts is to Buy stock in Bayer. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.